Initiating Stimulant Therapy for Adult Male Patients with Attention Deficit Hyperactivity Disorder (ADHD)

Pre-Treatment Assessment and Contraindications

The American Academy of Child and Adolescent Psychiatry recommends beginning with methylphenidate 5 mg twice daily or dextroamphetamine/amphetamine 2.5 mg twice daily after confirming the absence of contraindications through baseline cardiovascular assessment 1
A physical examination with baseline blood pressure, pulse, height, and weight is necessary before initiating stimulant medication, as recommended by the American Academy of Child and Adolescent Psychiatry 1
The American Academy of Child and Adolescent Psychiatry advises against initiating stimulants in patients with previous sensitivity to stimulant medications, glaucoma, hyperthyroidism, uncontrolled hypertension, active psychotic disorder, or current or recent MAO inhibitor use 1
The American Academy of Child and Adolescent Psychiatry also recommends considering the patient's substance use history, particularly in adults, as stimulants must be used with great care if there is a history of drug abuse 1

Methylphenidate is recommended as the initial stimulant due to more favorable effects on appetite and sleep compared to amphetamines, which have longer excretion half-lives, as suggested by the American Academy of Child and Adolescent Psychiatry 1
The American Academy of Child and Adolescent Psychiatry recommends starting with methylphenidate 5 mg twice daily or dextroamphetamine/amphetamine 2.5 mg twice daily 1
The dosing range for adults is methylphenidate 5-20 mg three times daily or dextroamphetamine 5 mg three times daily to 20 mg twice daily, according to Praxis Medical Insights 2

The American Academy of Child and Adolescent Psychiatry recommends using minimum effective doses to initiate therapy and establishing both minimum and maximum dose targets before starting 1
A consistent titration schedule with regular assessment of drug response is necessary, as suggested by the American Academy of Child and Adolescent Psychiatry 1
Stimulants work rapidly, allowing quick assessment of ADHD symptom response within days, with an expected response rate of 70-80% for pure ADHD treatment, according to Praxis Medical Insights 2

The American Academy of Child and Adolescent Psychiatry recommends checking vital signs annually during routine physical examination for children and adolescents, and quarterly for adults 1
Monitor for larger changes in heart rate and blood pressure, as 5-15% of individuals may experience substantial increases requiring intervention, as noted by Praxis Medical Insights 3
The American Academy of Child and Adolescent Psychiatry advises monitoring for appearance or worsening of aggressive behavior or hostility, new psychotic or manic symptoms, and behavioral disturbances in patients with pre-existing conditions 1

Expect and counsel patients about decreased appetite, sleep disturbances, increased blood pressure and pulse, headaches, irritability, and stomach pain, as reported by Pharmacology and Therapeutics 5
These effects are generally mild and/or temporary, according to Pharmacology and Therapeutics 5
Hold medication immediately and obtain ECG plus cardiology consultation if patient develops dyspnea, exercise-induced symptoms, or other cardiac symptoms, as recommended by Praxis Medical Insights 6

Patients with seizure history should have their disorder controlled with anticonvulsants before initiating stimulant therapy, as advised by the American Academy of Child and Adolescent Psychiatry 1
Patients with comorbid depression can be treated concurrently with stimulants, and depression is not a contraindication to stimulant therapy, according to Praxis Medical Insights 2
Patients with substance abuse history should consider long-acting formulations with lower abuse potential or non-stimulant alternatives like atomoxetine, as recommended by Praxis Medical Insights 2

If stimulants are contraindicated, not tolerated, or ineffective after optimization, atomoxetine (60-100 mg daily) is the only FDA-approved non-stimulant for adult ADHD, though it requires 2-4 weeks to achieve full effect, as noted by Praxis Medical Insights 2